These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 13981962)

  • 1. Upper hemibody infusion with alkylating agents for advanced lung cancer.
    RHEINLANDER HF; MILLER HH; MOQUIN RB; DETERLING RA
    J Thorac Cardiovasc Surg; 1962 Dec; 44():801-12. PubMed ID: 13981962
    [No Abstract]   [Full Text] [Related]  

  • 2. Palliative treatment of nonresectable lung cancer by upper hemibody perfusion of chlorimine (short-acting alkylating agent): experience with five cases.
    Sher MH; Trummer MJ; Moquin RB
    Am Surg; 1966 Jun; 32(6):385-7. PubMed ID: 4160225
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen mustard in the treatment of bronchogenic carcinoma.
    Bernstock L
    Nurs Times; 1969 Jul; 65(28):875-7. PubMed ID: 5789339
    [No Abstract]   [Full Text] [Related]  

  • 4. Evaluation of nitrogen mustard in prolonging life of patients with bronchogenic carcinoma.
    WOLF J; YESNER R; PATNO ME
    Cancer Chemother Rep; 1962 Feb; 16():473-5. PubMed ID: 14007937
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of inoperable cancer of the lung, bladder and liver by means of intra-arterial administration of alkylating agents and application of remote control vessel tourniquet; a preliminary report.
    Jozef Z; Tadeusz J
    Pol Med Sci Hist Bull; 1966 Oct; 9(4):178-80 passim. PubMed ID: 5920141
    [No Abstract]   [Full Text] [Related]  

  • 6. A controlled clinical trial with the cytostatic agent thyminalkylamine and its fluorinated derivative on advanced ovarian tumours.
    Dvorák O; Elis J; Perlík F; Kvícalová M; Jandová A; Skoda V; Kafka V
    Neoplasma; 1971; 18(4):365-9. PubMed ID: 5568931
    [No Abstract]   [Full Text] [Related]  

  • 7. FURTHER EXPERIENCE WITH COMBINED CYTOTOXIC THERAPY IN BRONCHIAL CARCINOMA.
    FELSTEIN IL
    Br J Clin Pract; 1963 Oct; 17():578-80. PubMed ID: 14066114
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined roentgen therapy and nitrogen mustard in carcinoma of the lung as compared to other methods.
    KRABBENHOFT KL; LEUCUTIA T
    Am J Roentgenol Radium Ther Nucl Med; 1958 Mar; 79(3):491-504. PubMed ID: 13508954
    [No Abstract]   [Full Text] [Related]  

  • 9. Nitrogen mustard perfusion of the isolated dog lung.
    BAXTER CF; GOSWITZ JT; PRATT PC; KLASSEN KP
    Surg Forum; 1960; 11():49-51. PubMed ID: 13688067
    [No Abstract]   [Full Text] [Related]  

  • 10. The use of chemotherapy for carcinoma of the lung.
    HARRIS MS
    J Int Coll Surg; 1960 Nov; 34():666-73. PubMed ID: 13711767
    [No Abstract]   [Full Text] [Related]  

  • 11. Role of lung transplantation in the treatment of bronchogenic carcinomas for patients with end-stage pulmonary disease.
    de Perrot M; Chernenko S; Waddell TK; Shargall Y; Pierre AF; Hutcheon M; Keshavjee S
    J Clin Oncol; 2004 Nov; 22(21):4351-6. PubMed ID: 15514376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The in vivo and in vitro neutralization of nitrogen mustard for use in cancer chemotherapy perfusion.
    SCHULTZ PE; BONUS RL; SALKIN MS; SCANLON EF
    Surg Gynecol Obstet; 1962 Jul; 115():91-100. PubMed ID: 14039071
    [No Abstract]   [Full Text] [Related]  

  • 13. Selected perfusion of isolated viscera with chemotherapeutic agents using an extracorporeal circuit.
    RYAN RF; KREMENTZ ET; CREECH O; WINBLAD JN; CHAMBLEE W; CHEEK H
    Surg Forum; 1957; 8():158-61. PubMed ID: 13529573
    [No Abstract]   [Full Text] [Related]  

  • 14. [Squamous cell bronchogenic carcinoma with syndrome of inappropriate secretion of antidiuretic hormone].
    Katsuragi N; Shiraishi Y; Nakajima Y; Kurai M; Takahashi N; Tanaka S
    Kyobu Geka; 2004 Aug; 57(9):847-50. PubMed ID: 15366568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Some aspects of advances in the chemotherapy of bronchogenic carcinoma].
    Skricková J; Pálková I; Spelda S; Babicková L; Kaplanová J; Kubová O
    Vnitr Lek; 2001 Aug; 47(8):561-7. PubMed ID: 15633398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lessons from a time capsule: evolution, not revolution, in therapy for advanced non-small-cell lung cancer.
    Green MR
    J Clin Oncol; 2008 Jul; 26(19):3112-3. PubMed ID: 18591551
    [No Abstract]   [Full Text] [Related]  

  • 17. [Multimodal treatment of non small cell lung cancer].
    Stoelben E; Digel W; Henke M; Passlick B
    Zentralbl Chir; 2006 Apr; 131(2):110-4. PubMed ID: 16612776
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cancer of the lung irradiated with the cobalt bomb (Histopathological study)].
    ABELLO J
    Rev Esp Tuberc; 1960 Aug; 29():355-86. PubMed ID: 13680998
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pharmacological characterization of cyclic nitrogen mustard phosphamide esters as cancer therapeutic agents].
    BROCK N
    Arzneimittelforschung; 1958 Jan; 8(1):1-9. PubMed ID: 13510143
    [No Abstract]   [Full Text] [Related]  

  • 20. MANAGEMENT OF COIN LESIONS AND CARCINOMA OF THE LUNG.
    BURDETTE WJ; EVANS C
    Ann Surg; 1965 May; 161(5):649-73. PubMed ID: 14289989
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.